[Intravenous immunoglobulin substitution in patients with multiple myeloma, Waldenstrom's syndrome and chronic lymphatic leukemia with secondary antibody deficiency syndrome].
D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000209:etiology / Q000628:therapy*; D007263:Infusions, Parenteral; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000628:therapy*; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy*; D011446:Prospective Studies; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology / Q000628:therapy*
D007074:Immunoglobulin G
Intravenöse Immunglobulin-Substitution bei Patienten mit multiplem Myelom, Morbus Waldenström und chronischer lymphatischer Leukämie mit sekundärem Antikörpermangelsyndrom.